611 related articles for article (PubMed ID: 36255681)
1. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
Sandhoff R; Sandhoff K
Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
[TBL] [Abstract][Full Text] [Related]
2. Emerging concepts of ganglioside metabolism.
Sandhoff R; Sandhoff K
FEBS Lett; 2018 Dec; 592(23):3835-3864. PubMed ID: 29802621
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside Metabolism in Health and Disease.
Sandhoff R; Schulze H; Sandhoff K
Prog Mol Biol Transl Sci; 2018; 156():1-62. PubMed ID: 29747811
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal Glycosphingolipid Storage Diseases.
Breiden B; Sandhoff K
Annu Rev Biochem; 2019 Jun; 88():461-485. PubMed ID: 31220974
[TBL] [Abstract][Full Text] [Related]
5. Multi-system disorders of glycosphingolipid and ganglioside metabolism.
Xu YH; Barnes S; Sun Y; Grabowski GA
J Lipid Res; 2010 Jul; 51(7):1643-75. PubMed ID: 20211931
[TBL] [Abstract][Full Text] [Related]
6. Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion.
Sandhoff K; Klein A
FEBS Lett; 1994 Jun; 346(1):103-7. PubMed ID: 8206147
[TBL] [Abstract][Full Text] [Related]
7. Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.
Wallom KL; Fernández-Suárez ME; Priestman DA; Te Vruchte D; Huebecker M; Hallett PJ; Isacson O; Platt FM
Glycoconj J; 2022 Feb; 39(1):39-53. PubMed ID: 34757540
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders.
Ryckman AE; Brockhausen I; Walia JS
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961778
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.
Breiden B; Sandhoff K
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272755
[TBL] [Abstract][Full Text] [Related]
10. Substrate reduction therapy for glycosphingolipid storage disorders.
Lachmann RH; Platt FM
Expert Opin Investig Drugs; 2001 Mar; 10(3):455-66. PubMed ID: 11227045
[TBL] [Abstract][Full Text] [Related]
11. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
Jeyakumar M; Butters TD; Dwek RA; Platt FM
Neuropathol Appl Neurobiol; 2002 Oct; 28(5):343-57. PubMed ID: 12366816
[TBL] [Abstract][Full Text] [Related]
12. Secondary accumulation of gangliosides in lysosomal storage disorders.
Walkley SU
Semin Cell Dev Biol; 2004 Aug; 15(4):433-44. PubMed ID: 15207833
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases.
Annunziata I; Sano R; d'Azzo A
Cell Death Dis; 2018 Feb; 9(3):328. PubMed ID: 29491402
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides in the Immune System: Role of Glycosphingolipids and Glycosphingolipid-Enriched Lipid Rafts in Immunological Functions.
Iwabuchi K
Methods Mol Biol; 2018; 1804():83-95. PubMed ID: 29926405
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside Metabolism and Its Inherited Diseases.
Breiden B; Sandhoff K
Methods Mol Biol; 2018; 1804():97-141. PubMed ID: 29926406
[TBL] [Abstract][Full Text] [Related]
16. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
17. The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases.
Shayman JA; Larsen SD
J Lipid Res; 2014 Jul; 55(7):1215-25. PubMed ID: 24534703
[TBL] [Abstract][Full Text] [Related]
18. Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation.
Schulze H; Kolter T; Sandhoff K
Biochim Biophys Acta; 2009 Apr; 1793(4):674-83. PubMed ID: 19014978
[TBL] [Abstract][Full Text] [Related]
19. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
[TBL] [Abstract][Full Text] [Related]
20. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
Sandhoff K
Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
